Jon L. Wright

412 total citations
19 papers, 352 citations indexed

About

Jon L. Wright is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Jon L. Wright has authored 19 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cellular and Molecular Neuroscience, 11 papers in Molecular Biology and 7 papers in Organic Chemistry. Recurrent topics in Jon L. Wright's work include Neuroscience and Neuropharmacology Research (7 papers), Receptor Mechanisms and Signaling (7 papers) and Synthesis of heterocyclic compounds (4 papers). Jon L. Wright is often cited by papers focused on Neuroscience and Neuropharmacology Research (7 papers), Receptor Mechanisms and Signaling (7 papers) and Synthesis of heterocyclic compounds (4 papers). Jon L. Wright collaborates with scholars based in United States, Netherlands and Canada. Jon L. Wright's co-authors include Lawrence D. Wise, Tracy F. Gregory, Robert G. MacKenzie, Thomas G. Heffner, Thomas A. Pugsley, Richard M. Woodward, Edward R. Whittemore, Leonard T. Meltzer, Zhang‐Lin Zhou and Christopher S. Konkoy and has published in prestigious journals such as Brain Research, Journal of Medicinal Chemistry and Tetrahedron Letters.

In The Last Decade

Jon L. Wright

19 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jon L. Wright United States 10 178 160 153 32 18 19 352
Jean Morrone United States 9 191 1.1× 138 0.9× 168 1.1× 23 0.7× 15 0.8× 9 363
Kevin M. Thewlis United Kingdom 12 315 1.8× 123 0.8× 259 1.7× 16 0.5× 17 0.9× 18 485
Elżbieta Ber United States 7 284 1.6× 82 0.5× 195 1.3× 13 0.4× 17 0.9× 10 424
Johannes Schütz Austria 14 217 1.2× 139 0.9× 248 1.6× 19 0.6× 15 0.8× 24 494
Motonori Miyakawa Japan 12 213 1.2× 102 0.6× 84 0.5× 20 0.6× 16 0.9× 13 416
Thomas A. Pugsley United States 11 213 1.2× 166 1.0× 212 1.4× 21 0.7× 8 0.4× 12 442
Antonio Vong United Kingdom 12 239 1.3× 248 1.6× 166 1.1× 11 0.3× 23 1.3× 21 495
Shelly A. Glase United States 10 179 1.0× 139 0.9× 138 0.9× 22 0.7× 17 0.9× 12 323
Hervé Geneste Germany 14 193 1.1× 258 1.6× 76 0.5× 43 1.3× 17 0.9× 33 436
Julianne M. Yost United States 7 330 1.9× 169 1.1× 214 1.4× 16 0.5× 12 0.7× 11 512

Countries citing papers authored by Jon L. Wright

Since Specialization
Citations

This map shows the geographic impact of Jon L. Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon L. Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon L. Wright more than expected).

Fields of papers citing papers by Jon L. Wright

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon L. Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon L. Wright. The network helps show where Jon L. Wright may publish in the future.

Co-authorship network of co-authors of Jon L. Wright

This figure shows the co-authorship network connecting the top 25 collaborators of Jon L. Wright. A scholar is included among the top collaborators of Jon L. Wright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon L. Wright. Jon L. Wright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Walter, Joan, et al.. (2015). Integrative Health and Healing Practices Specifically for Service Members: Self-Care Techniques. Medical Acupuncture. 27(5). 335–343. 3 indexed citations
2.
Konkel, Michael J., Bharat Lagu, Lakmal W. Boteju, et al.. (2006). 3-Arylimino-2-indolones Are Potent and Selective Galanin GAL3 Receptor Antagonists. Journal of Medicinal Chemistry. 49(13). 3757–3758. 43 indexed citations
3.
Nikam, Sham S., Jon L. Wright, Suzanne R. Kesten, et al.. (2004). Subtype selective NMDA receptor antagonists: evaluation of some novel alkynyl analogues. Bioorganic & Medicinal Chemistry Letters. 14(5). 1213–1216. 7 indexed citations
4.
5.
Gregory, Tracy F., Jon L. Wright, Lawrence D. Wise, et al.. (2000). Parallel synthesis of a series of subtype-selective NMDA receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 10(6). 527–529. 8 indexed citations
6.
Guzikowski, Anthony P., Amir P. Tamiz, Sui Xiong Cai, et al.. (2000). Synthesis of N-Substituted 4-(4-Hydroxyphenyl)piperidines, 4-(4-Hydroxybenzyl)piperidines, and (±)-3-(4-Hydroxyphenyl)pyrrolidines:  Selective Antagonists at the 1a/2B NMDA Receptor Subtype. Journal of Medicinal Chemistry. 43(5). 984–994. 35 indexed citations
7.
Wright, Jon L., Tracy F. Gregory, Christopher F. Bigge, et al.. (1999). Subtype-Selective N-Methyl-d-aspartate Receptor Antagonists:  Synthesis and Biological Evaluation of 1-(Arylalkynyl)-4-benzylpiperidines. Journal of Medicinal Chemistry. 42(13). 2469–2477. 85 indexed citations
8.
Wright, Jon L., Tracy F. Gregory, Peter A. Boxer, et al.. (1999). Discovery of subtype-selective NMDA receptor ligands: 4-Benzyl-1-piperidinylalkynylpyrroles, pyrazoles and imidazoles as NR1a/2B antagonists. Bioorganic & Medicinal Chemistry Letters. 9(19). 2815–2818. 15 indexed citations
9.
Boer, Peter de, Paolo Enrico, Jon L. Wright, et al.. (1997). Characterization of the effect of dopamine D3 receptor stimulation on locomotion and striatal dopamine levels. Brain Research. 758(1-2). 83–91. 32 indexed citations
10.
Wright, Jon L., Tracy F. Gregory, Thomas G. Heffner, et al.. (1997). Discovery of selective dopamine D4 receptor antagonists: 1-Aryloxy-3-(4-aryloxypiperidinyl)-2-propanols. Bioorganic & Medicinal Chemistry Letters. 7(11). 1377–1380. 32 indexed citations
11.
Wright, Jon L.. (1997). Design and discovery of neuropeptide Y1 receptor antagonists. Drug Discovery Today. 2(1). 19–24. 7 indexed citations
12.
Wright, Jon L., Gary L. Bolton, Dennis M. Downing, et al.. (1996). ChemInform Abstract: 8‐Amino‐6‐(arylsulfonyl)‐5‐nitroquinolines: Novel Nonpeptide Neuropeptide Y1 Receptor Antagonists.. ChemInform. 27(49). 1 indexed citations
13.
Glase, Shelly A., Hyacinth C. Akunne, Thomas G. Heffner, et al.. (1996). 4-bromo-1-methoxy-N-[2-(4-aryl-1-piperazinyl)ethyl]-2-naphthalenecarboxamides: Selective dopamine D3 receptor partial agonists. Bioorganic & Medicinal Chemistry Letters. 6(12). 1361–1366. 13 indexed citations
14.
Wright, Jon L., Gary L. Bolton, Dennis M. Downing, et al.. (1996). 8-amino-6-(arylsulphonyl)-5-nitroquinolines: novel nonpeptide neuropeptide Y1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 6(15). 1809–1814. 23 indexed citations
15.
16.
Wright, Jon L., Dennis M. Downing, Thomas G. Heffner, et al.. (1995). Discovery of selective dopamine D3 ligands: I. Dimeric 2-[4-(3-aminopropoxy)phenyl]benzimidazole antagonists. Bioorganic & Medicinal Chemistry Letters. 5(21). 2541–2546. 6 indexed citations
17.
Wright, Jon L., Thomas G. Heffner, Thomas A. Pugsley, Robert G. MacKenzie, & Lawrence D. Wise. (1995). Discovery of selective dopamine D3 ligands: II. 2-[4-[3-(4-aryl-1-piperazinyl)propoxy]phenyl]benzimidazole partial agonists. Bioorganic & Medicinal Chemistry Letters. 5(21). 2547–2550. 6 indexed citations
18.
Wright, Jon L., Bradley W. Caprathe, Dennis M. Downing, et al.. (1994). The Discovery and Structure-Activity Relationships of 1,2,3,6-Tetrahydro-4-phenyl-1-[(arylcyclohexenyl)alkyl]pyridines. Dopamine Autoreceptor Agonists and Potential Antipsychotic Agents. Journal of Medicinal Chemistry. 37(21). 3523–3533. 18 indexed citations
19.
Walter, James & Jon L. Wright. (1979). 13C-15N spin-spin coupling constants of amides: H-bonding effects in a cyclohexapeptide. Tetrahedron Letters. 20(41). 3909–3912. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean Morrone Breakdown of academic impact, for papers by Kevin M. Thewlis Breakdown of academic impact, for papers by Elżbieta Ber Breakdown of academic impact, for papers by Johannes Schütz Breakdown of academic impact, for papers by Motonori Miyakawa Breakdown of academic impact, for papers by Thomas A. Pugsley Breakdown of academic impact, for papers by Antonio Vong Breakdown of academic impact, for papers by Shelly A. Glase Breakdown of academic impact, for papers by Hervé Geneste Breakdown of academic impact, for papers by Julianne M. Yost
Rankless by CCL
2026